Bronchopulmonary dysplasia: an update of current pharmacologic therapies and new approaches

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - journals.sagepub.com
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …
被引用次数：89 相关文章

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - search.ebscohost.com
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - search.proquest.com
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine Insights …, 2018 - cir.nii.ac.jp
抄録< jats: p> Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term
morbidity of surviving extremely preterm infants and is associated with significant health care …

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - europepmc.org
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …
[PDF] academia.edu

[PDF][PDF] Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Z Michael, F Spyropoulos, S Ghanta, H Christou - 2018 - academia.edu
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Z Michael, F Spyropoulos… - Clinical medicine …, 2018 - pubmed.ncbi.nlm.nih.gov
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …
[HTML] nih.gov

[HTML][HTML] Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - ncbi.nlm.nih.gov
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - europepmc.org
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …